What are the opening hours?

Monday 8am - 6pm Tuesday 8am - 6pm Wednesday 8am - 6pm Thursday 8am - 6pm Friday 9am - 6pm

Carterra

Name: Carterra
Address: 825 N. 300 W, Suite C309, Salt Lake City, UT, 84103, US
Telephone: +18446427635

High-throughput discovery and characterization technology Carterra, Inc. For additional information, please visit www.carterra-bio.com.

Carterra® is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra's high throughput LSA, LSAXT, and Ultra platforms for monoclonal antibody (mAb) and small molecule screening and characterization combine patented microfluidics technology with real-time High-Throughput Surface Plasmon Resonance (HT-SPR) and industry-leading ana

lysis and visualization software. These systems deliver up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing label-free platforms. The LSAXT and Ultra instruments introduce enhancements to Carterra’s flagship product, the LSA, increasing sensitivity and enabling new applications in biotherapeutic discovery and small molecule analysis. is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester, England, and Munich, Germany. Carterra products are available in Asia-Pacific and Oceania through our exclusive distributor, Revvity.

07/27/2026

Leerink Partners has identified Carterra’s HT-SPR technology as a primary enabler in the Lab-in-the-Loop approach to AI-driven antibody discovery.

As AI generates more antibody candidates, high-quality binding data in large quantity becomes more important. That's where high-throughput SPR comes in. Carterra is enabling its AI customers to generate affinity, kinetics and epitope information using gold standard SPR for thousands of candidates a week, with minute sample use.

We're excited to see independent validation of what we're hearing from customers every day.

Read the full announcement: https://carterra-bio.com/news/leerink-partners-report-names-carterra-a-core-enabler-of-the-7b-lab-in-the-loop-antibody-discovery-market/

06/09/2026

Immuto Scientific's Hetal Marble, PhD will be at our Boston symposium to present how multimodal AI—combining structural, bioanalytical, and functional datasets with deep learning—is helping improve antibody-antigen modeling and accelerate biologics optimization.

Join her and other speakers from AstraZeneca, GSK, Merck and Carterra at this free drug discovery symposium. Register now: https://info.carterra-bio.com/boston-symposium-2026

06/04/2026

Cradle’s Michelle Vandeloo and Emma Beadle will present at Carterra's Amsterdam Symposium where they will take a closer look at scalable, data-rich workflows powering next-generation protein engineering. Cradle is combining automated HT-SPR on the Carterra platform with machine learning to accelerate antibody engineering—from SARS-CoV-2 VHH optimization to polyspecific snake antivenom discovery.

With other speakers from AVS Bio, AstraZeneca, GSK, and University of Oxford, this is a key event to learn about the latest in drug discovery.

Save your spot now: https://carterra-bio.com/free-symposia-2026-unlocking-high-throughput-biology/

06/03/2026

Exciting new work from Erica Ollmann Saphire, PhD, President & CEO, and the La Jolla Institute for Immunology team showcases potent human antibodies with broad measles virus neutralization and therapeutic protection.

Using Carterra’s high-throughput SPR technology for antibody characterization, including binding kinetics and epitope binning, the team mapped key antibody interactions that could help advance next-generation antiviral and therapeutic antibody discovery.

Read the full paper here: https://carterra-bio.com/resources/human-neutralizing-antibodies-targeting-the-measles-virus-hemagglutinin-and-fusion-surface-proteins/

06/02/2026

GSK’s Katie Smith will present at our Amsterdam symposium how high-throughput kinetic and epitope binning workflows on the Carterra LSA-XT are helping accelerate early antibody discovery and streamline candidate selection across teams.

Join Katie, and other prestigious speakers from AstraZeneca, AVSBio, Cradle, and University of Oxford to hear the latest in drug discovery. Register now: https://carterra-bio.com/free-symposia-2026-unlocking-high-throughput-biology/

05/29/2026

High-throughput SPR is important for large-scale characterization workflows in drug discovery. Hosted by DDW, watch our on-demand webinar to learn how the Carterra Vega 48-channel SPR platform enables parallel kinetic and affinity analysis across diverse biologic and small molecule screening applications.

Register here to watch on demand: https://info.edifydigitalmedia.com/webinar-scale-your-drug-discovery-programme-by-12x-introducing-the-worlds-first-48-channel-spr-platform-may-2026

05/28/2026

More antibody hits don’t always mean better leads. The real advantage comes from knowing which promising candidates to move forward.

AVS Bio’s Ilse Roodink, Ph.D., symposium co-host, is one of several esteemed presenters at Carterra's Amsterdam symposium, and will present how combining high-throughput SPR profiling with 𝘪𝘯 𝘴𝘪𝘭𝘪𝘤𝘰 developability optimization is helping teams turn diverse discovery outputs into stronger lead candidates, faster.

Don't miss Ilse, and others from AstraZeneca, Cradle, GSK, and University of Oxford on June 25th. Register now to save your seat: https://carterra-bio.com/free-symposia-2026-unlocking-high-throughput-biology/

05/27/2026

AstraZeneca’s Jon Barricelli will explore at Carterra’s Boston symposium how SPR kinetics shift between 25°C and 37°C and the impact of thermodynamics in candidate selection.

Join speakers from GSK, Immuto Scientific, and Merck for a day of insights into high-throughput biology and biologics discovery. Save your spot now: https://carterra-bio.com/free-symposia-2026-unlocking-high-throughput-biology/

05/26/2026

Xaira Therapeutics’ Ha Dang, PhD, will discuss at our upcoming San Francisco-area symposium how Xaira combines cell-free protein synthesis with high-throughput SPR to rapidly screen binders while simultaneously checking for polyreactivity and data quality; one workflow to identify promising therapeutic candidates.

Join Dr. Dang and other industry-leading scientists from Absci, Medra and Prellis to hear the latest in drug discovery research: https://carterra-bio.com/free-symposia-2026-unlocking-high-throughput-biology/

05/21/2026

Biologics discovery is getting faster!

At the Carterra Amsterdam Symposium, Alice Webb, PhD of AstraZeneca, will share how advances in high-throughput SPR are enabling rapid profiling across diverse modalities and feeding data directly into AI-driven lead optimization.

Join Dr. Webb alongside other industry leaders exploring the latest advances in biologics discovery, AI, and high-throughput characterization from AVS Bio, Cradle, GSK, and University of Oxford. Save your spot: https://carterra-bio.com/free-symposia-2026-unlocking-high-throughput-biology/

Address

825 N. 300 W, Suite C309
Salt Lake City, UT
84103

Opening Hours

Monday	8am - 6pm
Tuesday	8am - 6pm
Wednesday	8am - 6pm
Thursday	8am - 6pm
Friday	9am - 6pm

Telephone

+18446427635

Website

https://carterra-bio.com/contact/

Alerts

Be the first to know and let us send you an email when Carterra posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Carterra:

Want your business to be the top-listed Business in Salt Lake City?